Outcome of Patients with Accelerated and Blast-Phase Myeloproliferative Neoplasms Ineligible for Intensive Chemotherapy or Allogeneic Hematopoietic Cell Transplantation Treated by Azacitidine Alone or in Combination-a FIM StudyCorentin Orvain,Suzanne Tavitian,Clemence Mediavilla,Francoise Boyer,Alberto Santagostino,Geoffroy Venton, Samia Madene,Tony Marchand,Pascal Turlure,Diane Lara,Lenaig Le Clech,Katell Le Du,Jean-Baptiste Robin,Lise Willems,Anaise Blouet,Thomas Systchenko,Mathieu Wemeau,Helene Pasquer,Melanie Mercier,Christophe Nicol,Laurence Legros,Antoine Machet,Franck E. Nicolini,Lydia Roy,Clementine Salvado,Elsa Lestang,Guillaume Denis,Kamel Laribi,Eric Lippert,Lina Benajiba,Jean-Christophe IanottoBLOOD(2024)Cited 0|Views4AI Read ScienceMust-Reading TreeExampleGenerate MRT to find the research sequence of this paperChat PaperSummary is being generated by the instructions you defined